Rapid Prostate Cancer Test

The Prostate Specific Antigen (PSA) Rapid Test is an immunoassay that is based on a colloidal gold/antibody complex and is intended for the qualitative determination of human prostate specific antigen in whole blood, serum, or plasmas.input:
output:Prostate cancer is one of the most prevalent forms of cancer in men. The number of newly diagnosed patients is increasing as the incidence of prostate cancer increases with age. Prostate specific antigen (PSA) is primarily produced in the prostate gland and is secreted into the prostate ducts. It is responsible for liquefying the seminal coagulum during ejaculation. The PSA concentration of nearly all healthy males under the age of 50 is less than 4 ng/mL. The patient is most likely to have prostate cancer if their PSA level exceeds 10 ng/mL. Certain studies have suggested that serum from patients with prostate cancer cells that have metastasized throughout their bodies contains elevated total PSA levels. In patients with benign prostatic hyperplasia, free PSA is more prevalent, as it is incapable of forming a complex with serine protease, according to additional research.input:
output:The following are the features:Two band results for straightforward interpretation br/>
Room temperature storage or refrigerated (2-30⁰C)

Incorporated internal controlReagents are included.SpecificationsCut-off: 4 ng/mLShelf life: 24 months from the date of manufacture